EP0550531A1 - Identification d'organismes - Google Patents
Identification d'organismesInfo
- Publication number
- EP0550531A1 EP0550531A1 EP91916841A EP91916841A EP0550531A1 EP 0550531 A1 EP0550531 A1 EP 0550531A1 EP 91916841 A EP91916841 A EP 91916841A EP 91916841 A EP91916841 A EP 91916841A EP 0550531 A1 EP0550531 A1 EP 0550531A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- probe
- nucleic acid
- probes
- organisms
- hybridisation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000523 sample Substances 0.000 claims abstract description 110
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 38
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 37
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 37
- 238000009396 hybridization Methods 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 27
- 238000003752 polymerase chain reaction Methods 0.000 claims abstract description 14
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 108020004414 DNA Proteins 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 8
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 4
- 239000002751 oligonucleotide probe Substances 0.000 claims description 4
- 108700022487 rRNA Genes Proteins 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 102000053602 DNA Human genes 0.000 claims 4
- 108020004682 Single-Stranded DNA Proteins 0.000 claims 4
- 239000003298 DNA probe Substances 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 9
- 238000012216 screening Methods 0.000 abstract description 5
- 239000013615 primer Substances 0.000 description 20
- 241000894007 species Species 0.000 description 8
- 108020004465 16S ribosomal RNA Proteins 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 241000430519 Human rhinovirus sp. Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000701806 Human papillomavirus Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241001631646 Papillomaviridae Species 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 241000203024 Acholeplasma Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 241000194041 Lactococcus lactis subsp. lactis Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001430197 Mollicutes Species 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 1
- 241001180364 Spirochaetes Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- ZKHQWZAMYRWXGA-MVKANHKCSA-N [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxy(32P)phosphoryl] phosphono hydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO[32P](O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-MVKANHKCSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 238000009595 pap smear Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 229940016590 sarkosyl Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- the present invention relates to the identification of organisms, particularly microorganisms, and especially eubacteria.
- one aspect of the invention provides a method of identifying an organism, the method comprising (1) obtaining nucleic acid derived from the organism, and (2) determining, for each of at least 5 nucleotide probes, whether the probe hybridises to the said nucleic acid.
- the number of probes used is at least 10, 15, 20, 25 or more when one wishes to distinguish between large numbers of samples (for example hundreds) .
- 10-20 would typically be enough in such a situation to establish a meaningful signature, provided that each probe does not hybridise so seldom or so frequently to the sample nucleic acid as to give the same highly negative or highly positive hybridisation signature to all the samples which one is testing and between which one wishes to differentiate.
- fewer probes will usually be needed.
- probes bind to more than one site on the sample nucleic acid, since each probe is then capable of yielding more than a binary "yes/no" result and nucleic acid which binds the probe three times can be differentiated from nucleic acid which binds it only once or twice.
- the key feature of the methods of the present invention is that a plurality of short probes are used in concert to generate an informative "hybridisation signature".
- a second aspect provides a method of assigning a "hybridisation signature" to a given organism's nucleic acid based on its pattern of hybridisations to more than one oligonucleotide probe.
- each probe is such that, under appropriate hybridisation conditions, it will bind to about 25-75% of all nucleic acid of the types being assayed, preferably 30-70%, more preferably 40-60% and most preferably 40-50%.
- Each probe whilst being specific (subject to the hybridisation conditions) for a given sequence corresponding to the length of the probe, is non-specific in the sense that, on its own, it cannot be used with any precision to distinguish between different lengths of nucleic acid which are all significantly longer than the probe.
- the specificity of the assay method thus derives from the fact that a relatively high number of probes are used.
- the probes are typically 4-15 nucleotides long, preferably 5-10 and often 8 or 9 nucleotides long.
- a mixture of two or more similar probes can be treated as a single probe (ie used in a single hybridisation step) to increase the frequency with which the composite probe binds to sample nucleic acid.
- probe is used in this specification to include such composite probes.
- analogues and fragments thereof are those which provide for specific amplification by the PCR of DNA adjoining that to which the said four specific primers hybridise.
- Probes and primers can be made by known means, for example by simple chemical synthesis using apparatus supplied by Applied Biosystems Inc.
- nucleic acid in each sample can be arranged to be the same in each case, or can be measured by some other means, it is convenient to normalise the amount by determining the extent of binding of a probe which is known to be common to all of the samples under consideration, for example one in a highly conserved region. Such probes are hereinafter termed “conserved probes", as opposed to the previously discussed “variable probes” . The binding of the variable probes is then expressed as a ratio to the binding of the conserved probes. conserved probes are not subject to the same size constraints as variable probes.
- Probes may comprise all or part of the sequence of a PCR primer.
- the identification of the organism which is achieved by methods in accordance with the invention may be more or less precise according to how many probes are used and may be more or less informative according to what reference data one has for the same and other organisms.
- the methods may be used to place the organism in any of the taxonomic groups (Kingdom, phylum, class, sub-class, order, sub-order, family, genus, species or sub-species), to identify similarities with organisms having desirable or undesirable characteristics or even to identify the particular strain of organism.
- the methods are particularly useful in screening microorganisms, especially bacteria, which are collected more or less randomly from the wild to determine whether the sample microorganism has been studied previously or whether it falls into a group of microorganisms which are believed to be of particular interest.
- Another use for the methods of the invention is to identify, at least to an extent, the nature of a pathogen.
- papillomaviruses which are found must be typed, especially to determine whether they are type 16 or type 18, the two types thought to be responsible for cervical cancers and other abnormalities.
- probes which generate only binary hybridisation signatures (binding or not binding) then six probes may be necessary to distinguish between 35-60 types (as 2 6 is 64) . However, fewer probes may be employed if the probes bind multiply or if one wishes only to know whether the virus is type 16 or 18 or another type.
- probes may be used, with consequent savings of time and materials. It should be noted that the probes are not individually capable of specifically binding to a sequence motif unique to the virus type in question; it is still the hybridisation signature obtained by the use of a plurality of probes which yields the desired information.
- Further uses include the typing of other pathogens, for example HIV, rhinoviruses and Streptococcus species, and the typing of desirable or undesirable bacterial and viral strains in cheese-making, for example the lysin-producing bacteriophages and the desirable bacteria Lactococcus lactis subsp. lactis and subs, cremori ⁇ .
- pathogens for example HIV, rhinoviruses and Streptococcus species
- desirable or undesirable bacterial and viral strains in cheese-making for example the lysin-producing bacteriophages and the desirable bacteria Lactococcus lactis subsp. lactis and subs, cremori ⁇ .
- the methods of the invention are generally applicable to identifying or typing viruses, bacteria, mycoplasmas
- Plants including trees
- Plants may be typed as an initial screening process to identify those most likely to be useful in some context (for example desirable bread-making strains of wheat, oil- or pharmaceutical- bearing plants or nutritionally valuable or disease- resistant strains of crop plants) and this may be particularly valuable as part of a plant breeding program where one may otherwise have to wait until the hybrid is mature before being able to identify its characteristics.
- the nucleic acid which is probed may be DNA, RNA or cDNA.
- the method may involve any suitable combination of nucleic acid and probe.
- This includes, but is not limited to, chromosomal nucleic acid isolated in toto (DNA) , ribonucleic acid, or specific nucleic acid regions amplified in order to increase the sensitivity of the method.
- specifically amplified nucleic acid the important concept is that regions of nucleic acid variability will be located between highly conserved nucleic acid sequences, such that oligonucleotide primers can be designed that will complement the conserved regions and will allow the amplification of the variable regions located in between them.
- suitable loci include the ribosomal RNA genes, such as the bacterial 16S and 23S genes, and regions between them.
- Primers are likely to consist of oligonucleotides of length appropriate to their use in the polymerase chain reaction.
- Probes are likely to consist of oligonucleotide nucleic acids between six and ten bases in length, tagged either radioactively or non- radioactively.
- the nucleic acids to be probed may be positioned on a support such as a nylon filter membrane.
- Hybridisation of the probes to the nucleic acids must allow sufficient specific hybrid molecules to form and to be detected. Accurate quantitation of the amounts of probe bound to each nucleic acid is important, and may be achieved through the use of storage phosphor screen autoradiography or by other means.
- Figure 1 shows partial DNA sequences from the 16S ribosomal RNA genes of four bacteria
- Figure 2 illustrates the generation of distinct hybridisation signatures for four bacteria, using only two probes
- Figure 3 illustrates diagrammaticc.lly the use of six probes to generate respective hybridisation signatures for six organisms
- Figure 4 shows partial DNA sequences from several human papillomaviruses
- FIG. 5 shows partial sequences (as they might appear following reverse transcription) from four human rhinoviruses.
- Figure 1 shows nucleotide sequence alignments of the beginning of several 16S ribosomal RNA genes from different bacterial organisms.
- the sequence of the E. coli 16S rRNA gene is the reference sequence (GenEMBL Accession No J01695) .
- the next three sequences are from distantly related bacteria Streptomyces coelicolor, GenEMBL Accession No Y00411; Pseudoj ⁇ ionas aer ginosa , GenEMBL Accession No X06684; Pseudomonas testo ⁇ teroni, GenEMBL Accession No M11224) .
- a colon is used to indicate sequence conservation between the 16S rRNA sequence of these species and E . coli .
- the last two sequences are from two species of the same genus, and illustrate that variable regions remain variable even between two closely related species.
- Examples of the sequences of oligonucleotides used as primers for the polymerase chain reaction (PCR) are indicated by overlying arrows, and are termed Primer A and Primer B.
- Examples of the sequences of oligonucleotides used as probes in the hybridisation are underlined as Probe 1 (GACCCTCG, S . coel . ) and Probe 2 (CTGAGACAC, present in all species shown) .
- Oligonucleotides were synthesised on an Applied Biosystems 380A machine and labelled with [ ⁇ - 32 P]ATP (3000 Ci/mmol "1 ; Amersha International) and T4 polynucleotide kinase.
- the sequence of probes p3 and p4 were 5 '-CCACGTTG-3 ' and 5 '- TGCATGGC-3 ' , respectively.
- Hybridisation of probes to filters Filters were prehybridised for 30 minutes at room temperature in hybridisation solution (4X SSC, 7% sarkosyl) , then hybridised with probe at a concentration of 3nM for 3 hours at 80°C in a volume of 250 ⁇ l per 28 cm 2 filter. Filters were washed for one hour at 12°C in two changes of 100 ml of hybridisation solution, then exposed to either film or storage phosphor screens.
- Figure 2 is a schematic illustration of the hybridisation information obtained using four oligonucleotide probes (two as indicated in Figure 1) against a nylon filter membrane onto which the PCR products were spotted.
- Two separate regions of the 16S rRNA gene were amplified independently using primer pair A and B (as indicated in Figure 1) , or primer pair C and D.
- Probes pi and p2 were designed to be used as probes for nucleic acid samples from the region amplified using primer pair A and B; similarly, probes p3 and p4 for DNA from primer pair C and D.
- Hybridisations were done in .duplicate, and averages were used.
- Hybridisation signals were quantified by storage phosphor screen autoradiography, and signals from variable region probes (pi and p3) normalised against signals from conserved region probes (p2 and p4) .
- the four organisms classified by these means are shown to have been assigned four different hybridisation signatures.
- Figure 3 is a diagrammatic representation of the concept of assigning hybridisation signatures based on the accumulation of positive or negative assignments to each of six probes assayed against an array of nucleic acid samples.
- the number of different hybridisation signatures possible in any one set of experiments is, for experiments where only presence or absence is measured, 2 N where N is the number of probes used.
- the use of 20 probes in such an experiment yields 2 20 , ie over one million different (in this case, binary) hybridisation signatures.
- Each type of nucleic acid sample will reproducibly be assigned one of these signatures.
- the assay detects either 0, 1, or 2 copies of the probe in the nucleic acid of the organisms tested.
- Figure 4 shows nucleotide sequence alignments of portions of the genomes of several different human papillomaviruses, including two associated with a high risk of developing cervical cancer (Pphl6 and Pphl8) .
- a colon indicates nucleotide conservation between the sequences shown.
- Sequences for Pphll, Pphl6, Pphl ⁇ , and Pph33cg are from GenEMBL (Accession Numbers M14119, K02718, X05015, and M12732, respectively) .
- a pair of potential PCR primers are marked as primers E and F, and probes for both a non- conserved (probe 5) and a conserved (probe 6) region are indicated. The probes are prepared and used as in Example 1 above.
- Figure 5 shows nucleotide sequence alignments of portions of four human rhinovirus genomes as they might appear after reverse transcription. Sequence from human rhinoviruses types 14, 89, IB, and 2 are shown (from GenEMBL sequences, Accession Numbers X01087, M16248, D00239, and X02316, respectively) . As before, potential primers are indicated (Primers G and H) and an example is shown of both a probe from a variable region (probe 7 and a conserved region (probe 8) . The probes are prepared and used as in Example 1 above.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
On crible l'acide nucléique provenant d'organismes (amplifié généralement par une réaction de polymérase en chaîne -PCR) au moyen d'une banque de sondes courtes, afin de déterminer si chaque sonde s'hybride avec l'acide nucléique et, dans ce cas, combien de fois. On crée, de ce fait, une "signature d'hybridation" comportant un point (0, 1, 2, etc) pour chaque sonde. On peut utiliser le procédé pour effectuer un criblage initial de bactéries recueillies au hasard pour éliminer celles de type indésirable et celles étudiées précédemment, ainsi qu'également pour déterminer des organismes présentant un intérêt médical ou industriel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909020621A GB9020621D0 (en) | 1990-09-21 | 1990-09-21 | Identification of organisms |
| GB9020621 | 1990-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0550531A1 true EP0550531A1 (fr) | 1993-07-14 |
Family
ID=10682552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP91916841A Withdrawn EP0550531A1 (fr) | 1990-09-21 | 1991-09-20 | Identification d'organismes |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0550531A1 (fr) |
| JP (1) | JPH06501385A (fr) |
| GB (1) | GB9020621D0 (fr) |
| WO (1) | WO1992005280A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9210916D0 (en) * | 1992-05-21 | 1992-07-08 | Isis Innovation | Nucleic acid quantification |
| ES2158854T3 (es) * | 1992-10-13 | 2001-09-16 | Hoffmann La Roche | Oligonucleotidos derivados de la familia de genes sod. |
| CA2150986C (fr) * | 1994-06-17 | 1999-11-02 | Mary Kathryn Meyer | Amorces et sondes d'oligonucleotides pour la detection de bacteries |
| US5693467A (en) * | 1995-05-19 | 1997-12-02 | The American Type Culture Collection | Mycoplasma polymerase chain reaction testing system using a set of mixed and single sequence primers |
| DE19732086C2 (de) * | 1997-07-25 | 2002-11-21 | Univ Leipzig | Verfahren zur quantitativen Bestimmung von Eubakterien |
| GB9719044D0 (en) * | 1997-09-08 | 1997-11-12 | Inst Of Ophthalmology | Assay |
| US6821770B1 (en) | 1999-05-03 | 2004-11-23 | Gen-Probe Incorporated | Polynucleotide matrix-based method of identifying microorganisms |
| EP2365097A1 (fr) * | 1999-05-14 | 2011-09-14 | Enterprise Ireland (trading as BioResearch Ireland) | Analyses à base de sondes d'acide nucléique pour organismes procaryotes et eucaryotes |
| CN103451313B (zh) * | 2013-09-27 | 2016-03-09 | 中国科学院上海微系统与信息技术研究所 | 一种基因芯片的金沉积检测方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI71768C (fi) * | 1984-02-17 | 1987-02-09 | Orion Yhtymae Oy | Foerbaettrade nykleinsyrareagenser och foerfarande foer deras framstaellning. |
| AU5698286A (en) * | 1985-01-08 | 1987-04-24 | Biotechnica Limited | Determination of identity between two organisms |
| US4900659A (en) * | 1986-01-30 | 1990-02-13 | Enzo Biochem, Inc. | Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group |
| US5310893A (en) * | 1986-03-31 | 1994-05-10 | Hoffmann-La Roche Inc. | Method for HLA DP typing |
| WO1989005359A1 (fr) * | 1987-12-01 | 1989-06-15 | Integrated Genetics, Inc. | Detection de salmonelle |
| WO1989006704A1 (fr) * | 1988-01-11 | 1989-07-27 | Microprobe Corporation | Sondes d'oligonucleotides servant a la detection de pathogenes du periodonte |
| GB8810400D0 (en) * | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
| JPH02203800A (ja) * | 1988-04-15 | 1990-08-13 | Innogenetics Sa:Nv | ナイセリア菌株を検出するための交雑プローブ |
| FR2636075B1 (fr) * | 1988-09-07 | 1991-11-15 | Biotechnologie Ste Europ | Procede de detection des bacteries, levures, parasites et autres eucaryotes, notamment dans les produits alimentaires |
| IE81145B1 (en) * | 1989-04-20 | 2000-05-03 | Thomas Gerard Barry | Generation of specific probes for target nucleotide sequences |
-
1990
- 1990-09-21 GB GB909020621A patent/GB9020621D0/en active Pending
-
1991
- 1991-09-20 JP JP3515278A patent/JPH06501385A/ja active Pending
- 1991-09-20 EP EP91916841A patent/EP0550531A1/fr not_active Withdrawn
- 1991-09-20 WO PCT/GB1991/001618 patent/WO1992005280A1/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9205280A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06501385A (ja) | 1994-02-17 |
| GB9020621D0 (en) | 1990-10-31 |
| WO1992005280A1 (fr) | 1992-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU769566B2 (en) | Nucleic acid detection method | |
| US20030190663A1 (en) | Novel assay for nucleic acid analysis | |
| JPH06502312A (ja) | ミコバクテリアの核酸に相補的なオリゴヌクレオチド | |
| AU2007271709A1 (en) | Identification of pathogens | |
| US20150159207A1 (en) | Use of markers including nucleotide sequence based codes to monitor methods of detection and identification of genetic material | |
| KR20020008195A (ko) | 폴리뉴클레오티드 서열 변형의 미세배열-기초 분석 | |
| Weller et al. | Detection of root mat associated Agrobacterium strains from plant material and other sample types by post‐enrichment TaqMan PCR | |
| US9175339B2 (en) | Method for detection of target nucleic acid | |
| EP0550531A1 (fr) | Identification d'organismes | |
| CN111793712A (zh) | 小麦snp iwa586位点的单核苷酸多态性的物质的用途 | |
| Yoo et al. | Development of DNA microarray for pathogen detection | |
| Zhang et al. | Macroarray detection of solanaceous plant pathogens in the Fusarium solani species complex | |
| CA2928659A1 (fr) | Acides nucleiques et methodes de detection de pathogenes et de microorganismes utiles | |
| Verma et al. | Development and application of fluorescent loop mediated isothermal amplification technique to detect Phytophthora infestans from potato tubers targeting ITS-1 region | |
| Abaidoo et al. | Comparison of molecular and antibiotic resistance profile methods for the population analysis of Bradyrhizobium spp.(TGx) isolates that nodulate the new TGx soybean cultivars in Africa | |
| Vernet et al. | Species differentiation and antibiotic susceptibility testing with DNA microarrays | |
| EP2748320A2 (fr) | Compositions, procédés, et kits d'hybridation d'acides nucléiques | |
| Rossetti et al. | Improvement of Mycobacterium tuberculosis detection in clinical samples using DNA purified by glass matrix | |
| Mirmajlessi et al. | General principles of real-time PCR: a technology for quantitative detection of phytopathogens | |
| US7384770B1 (en) | Rapid quantification of acetic acid-producing bacteria using real-time PCR | |
| US7276358B1 (en) | Rapid quantification of butyric acid-producing bacteria using real-time PCR | |
| Flores-Gallegos et al. | Molecular Methods for Microorganism Detection | |
| Bashyal et al. | Real Time PCR-based Quantification and Expression Analysis of Candidate Genes | |
| WO2007115344A1 (fr) | Groupe d'oligonucléotides | |
| Wallis | The Effects of Land Use and Management Practices on Soil Microbial Diversity as Determined by PCR-DGGE and CLPP |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19930212 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Withdrawal date: 19940624 |